Teaching of Clinical Pharmacy in Bulgaria in the framework of the European Program ERASMUS+: the first experience

Authors

  • V. V. Propisnova National University of Pharmacy, Ukraine
  • S. B. Popov National University of Pharmacy, Ukraine
  • I. A. Zupanets National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/cphj.17.1424

Keywords:

clinical pharmacy, pharmaceutical care, education, ERASMUS

Abstract

The article is a report on the first experience of delivering lectures in clinical pharmacy by the Ukrainian teachers of the National University of Pharmacy in the countries of the European Union. The opportunity was provided thanks to the European Program ERASMUS+. In accordance with the requirements of the Program the National University of Pharmacy agreed to exchange specialists with the University of Medicine named after Professor Paraskev Stoyanov (Varna, Bulgaria), and within a four-day stay at the University 8 hours of lectures on the following topics were delivered: “The place and the role of clinical pharmacy in the modern healthcare system”, “Innovative and generic drugs: advantages and disadvantages”, “Clinical pharmacology and pharmaceutical care of NSAIDs: what is new?” and “Herbal drugs and modern medicine”.

The choice of the topics for lectures was not accidental. The lectures presented are the result of the teamwork of the staff of the Department of Clinical Pharmacology and Clinical Pharmacy of the NUPh. These topics are key, motivational and essential for the subject among more than 50 lectures on clinical pharmacy, clinical pharmacology, and pharmaceutical care delivered at the Department.

The article substantiates the necessity of the international exchange of the experience of the Ukrainian pharmaceutical education in the field of clinical pharmacy with foreign colleagues, describes the main content of lectures, notes the key issues posed in them.

Author Biographies

V. V. Propisnova, National University of Pharmacy

Candidate of Pharmacy (Ph.D.), associate professor of the Department of Clinical Pharmacology and Clinical Pharmacy

S. B. Popov, National University of Pharmacy

Doctor of Medicine (Dr. habil.), professor, vice-Rector for scientific and pedagogical work (international relations)

I. A. Zupanets, National University of Pharmacy

Doctor of Medicine (Dr. habil.), professor, head of the Clinical Pharmacology and Clinical Pharmacy Department

References

Brady, J. H., Caldwell, D. J., Pate, K. A., Pate, A. N. (2013). An Elective Course on Application of Clinical Pharmacy Principles. American Journal of Pharmaceutical Education, 77 (10). Available at: http://www.ajpe.org/doi/pdf/10.5688/ ajpe7710216

Melody, R., Hong, Sh., Li, Y. et al. (2008). Clinical Pharmacy education inChina. American Journal of Pharmaceutical Education, 72 (6), 129. Available at: http://www.ajpe.org/doi/pdf/10.5688 /aj7206129

Dovidnyk kvalifikatsiinykh kharakterystyk profesii pratsivnykiv: vyp. 78 «Ohorona zdorovia» (2002). M–vo okhorony zdorovia Ukrainy; M–vo pratsi ta sotsial. polityki Ukrainy. Kyiv, 205–207.

Postanova KMU. Pro zatverdzhennia pereliku haluzei znan i spetsialnostei, za yakymy zdiisniuietsia pidhotovka zdobuvachiv vyshhoi osvity vid 29 kvitnia 2015 r. № 266. Available at: http://zakon2.rada.gov.ua/laws/show/266–2015–p

Nakaz MON Ukrainy vid 29.07.2004 r. № 629. Pro zatverdzhennia skladovykh haluzevykh standartiv vyshchoi osvity zi spetsialnostei 7.110201 «Farmatsiia», 7.110202 «Tehnolohiia parfumerno–kosmetychnykh zasobiv», 7.110204 «Tehnolohiia farmatsevtychnykh preparativ», 7.110206 «Klinichna farmatsiia» napriamu pidhotovky 1102 «Farmatsiia» ta spetsialnosti 6.110100 «Laboratorna diahnostyka» napriamu pidhotovky 1101 «Medytsyna».

Consultation skills for pharmacy practice: practice standards for England (2014). Royal College of General Practitioners, 14. Available at: www.consultationskillsforpharmacy.com/docs/docc.pdf

Safe Effective Pharmacy Practice : Competence Standards For The Pharmacy Profession (2015). Pharmacy Council ofNew Zealand, 20–25. Available at: http://www.pharmacycouncil.org.nz/Portals/12/Documents/standardsguidelines/CompStds2015Web.pdf?ver=2017–02–20–104344–177

Professional Competencies for Canadian at Entry to Practice (2014). National Association of Pharmacy Regulatory Authorities, 11–13. Available at: http://napra.ca/content_files/files/ comp_for_cdn_pharmacists_at_ entrytopractice_march2014_b.pdf

Core Competency Framework For Pharmacists (2013). The Pharmaceutical Society Of Ireland, 18–21. Available at: http://www.thepsi.ie/Libraries/Publications/PSI_Core_Competency_Framework_for_Pharmacists.sflb.ashx

International Pharmaceutical Federation. FIP Education Initiative. In Quality Assurance of Pharmacy Education: The FIP Global Framework, 2nd ed. (2014). Available at: https://www.fip.org/files/fip/ PharmacyEducation/Quality_Assurance/QA_Framework_2nd_Edition_online_version.pdf

Zaharchenko, V. M., Lugovyi, V. I., Rashkevich, Yu. M., Talanova, Zh. V., Kremenia, V.G. (2014). Rozroblennia osvitnikh program. Kyiv: Prioritety, 120.

Sogokon, L., Sogokon, S. (2003). Provizor, 6. Available at: http://www.provisor.com.ua/archive/2003/N6/art_37.php

Proekt Yevropeiskoho Soiuzu Natsionalnyi Erazmus+ ofis – Ukraina. Available at: http://erasmusplus.org.ua/

Pro programu Yevropeiskoho Soiuzu – ERASMUS+ Ukraina. Available at: http://erasmusplus.org.ua/erasmus/ka1–navchalna–mobilnist/konkursy/kredytna–mobilnist.html/

Fakultet po farmatcyi. Available at: http://mu–varna.bg/BG/AboutUs/Pharmacy

Spetcialnosti. Farmatciia. Available at: http://mu–varna.bg/BG/AboutUs/Pharmacy/Pages/Specialities.aspx

Uchebnyi plan. Available at: http://mu–varna.bg/BG/Students/Documents/FF %20– %202016–2017/ucheben %20plan/ Ucheben %20plan.pdf

Derzhavnyi reiestr likarskykh zasobiv Ukrainy: Informatsiinyi fond: Statystyka. Available at: http://www.drlz.com.ua/

Eighth Futures Forum on Governance of Patient Safety (2005). Erfendorf, Austria. Available at: http://www.euro.who.int /__data/assets/pdf_file/0005/98285/E87770.pdf

Zareеckii, M. M. (2009). Therapia, 1 (33). Available at: http://therapia.ua/therapia/ 2009/01/vrachebnaya–oshibka–izbezhna–ili–net

Operational definition of medication error for EU reporting requirements (2013). Medication–errors workshop.London : European Medicine Agency. Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/Presentation/2013/03/WC500139871.pdf

National Action Plan for Adverse Drug Event Prevention (2014). Washington : U. S. Department of Health and Human Services. Available at: https://health.gov/hcq/pdfs/ade–action–plan–508c.pdf

Stawicki, S. P., Gerlach, A. T. (2009). Polypharmacy and medication errors: Stop, Listen, Look, and Analyze. OPUS 12 Scientist, 3 (1), 6–10.

Nakaz MOZ №875 vid 11.10.2013 r. Pro zatverdzhennia protokoliv provizora (farmatsevta) pry vidpusku bezretsepturnykh likarskykh zasobiv. Available at: http://www.moz.gov.ua/ua/portal/ dn_20131011_0875.html

Medication errors (2014). European Medicine Agency. Vienna : MedDRA User Group. Available at: https://www.meddra.org/sites/ default/files/training/file/medication_errors_ema.pdf

26. Struktura rynka lekarstvennykh sredstv v razreze rynochnogo statusa. Available at: http://www.apteka.ua/article/346577

Zupanetc, I. A., Podpruzhnikov, Yu. V., Golovenko, N. Ya., Bezuglaia, N. P., Borisiuk, I.Yu. (2010). Klinichna farmatsiia – Clinical farmacy, 14 (1), 18–23.

Rx index® – Dovidnyk ekvivalentnosti likarskykh zasobiv. (2016). Kyiv: Farmatsevt Praktyk, 848.

Persisting pain in children package: WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. Available at: http://apps.who.int/iris/bitstream/10665/44540/2/9789241548120_Pharmacists_Brochure.pdf

Rao, P., Knaus, E. E. (2008). Evolution of Nonsteroidal Anti–Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond. Journal of Pharmacy & Pharmaceutical Sciences, 11 (2), 81. doi:10.18433/j3t886

McGettigan, P., Henry, D. (2011). Cardiovascular risk with non–steroidal anti–inflammatory drugs: systematic review of population–based controlled observational studies. PLoS. Med., 8 (9). Available at: https://www.ncbi.nlm.nih.gov/pubmed/21980265

Schjerning Olsen, A.–M., Fosbol, E. L., Lindharsen, J. et al. (2011). Duration of treatment with NSAID and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction:a nationwide cohort study. Circulation, 123 (20), 2226–2235. doi: 10.1161/circulationaha.110.004671

Zupanets, I. A., Otrishko, I. A., Shebeko, S. K. (2009). Klinichna farmatsiia – Clinical farmacy, 13 (1), 42–46.

Zupanets, I. A., Tuliakov, V. A., Shebeko, S. K. (2012). Eksperimentalnaia i klinicheskaia farmakologiia, 75 (4), 34–37.

Usenko, V. F., Zupanets, I. A., Tarasenko, O. O., Shebeko, S. K. (2011). Ukrainskii revmatolohichnyi zhurnal, 3 (45), 62–66.

Kroon, F. P., van der Burg, L. R., Ramiro, S., Landewé, R. B., Buchbinder, R., Falzon, L., van der Heijde, D. (2015). Non–steroidal anti–inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non–radiographic axial spondyloarthritis). Cochrane Database of Systematic Reviews. doi: 10.1002/14651858.cd010952.pub2

Jones, P., Dalziel, S. R., Lamdin, R., Miles–Chan, J. L., Frampton, C. (2015). Oral non–steroidal anti–inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd007789.pub2

Kress, H., Baltov, A., Basinski, A. et al. (2016). Acute pain: a multifaceted challenge – the role of nimesulide. Curr. Med. Res. Opin., 32 (1), 23–36. doi: 10.1185/03007995. 2015.1100986

Petrick, J. L., Sahasrabuddhe, V. V., Chan, A. T., Alavanja, M. C., Beane–Freeman, L. E., Buring, J. E., McGlynn, K. A. (2015). NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project. Cancer Prevention Research, 8 (12), 1156–1162. doi:10.1158/1940–6207.capr–15–0126

Rogers, M. A. M., Aronoff, D. M. (2016). The influence of non–steroidal anti–inflammatory drugs on the gut microbiome. Clinical Microbiology and Infection, 22 (2), 178.e1–178.e9. doi:10.1016/j.cmi.2015.10.003

Sergienko, O. M., Zhigunova, A. K. (2013). Ukrainskyi medychnyi chasopis, 1 (93), 76–80.

Kunle O. F., Egharevba H. O., Ahmadu P. O. (2012). Standardization of herbal medicines – A review. International Journal of Biodiversity and Conservation, 4 (3). doi: 10.5897/ijbc11.163

Naber, K. (2013). Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia. Research and Reports in Urology, 39. doi: 10.2147/rru.s39288

Downloads

Published

2017-06-14

Issue

Vol. 21 No. 2 (2017)

Section

Clinical Pharmacology and Pharmacotherapy

License

Copyright (c) 2017 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).